Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
2002/12/17 by George Ostapowicz, Robert J. Fontana, Frank Vinholt Schiødt +18 · 36 citations
Pharmacology, Toxicology and Pharmaceutics · Medicine · #Drug-Induced Hepatotoxicity and Protection #Liver Disease and Transplantation #Hepatitis C virus research
paper · doi:10.7326/0003-4819-137-12-200212170-00007
Abstract
BACKGROUND: Because acute liver failure is rare, related data have been sparse. Studies have suggested that viral hepatitis is the most common underlying cause of this condition. OBJECTIVE: To describe the clinical features, presumed causes, and short-term outcomes of acute liver failure. DESIGN: Prospective cohort study. SETTING: 17 tertiary care centers participating in the U.S. Acute Liver Failure Study Group. PATIENTS: 308 consecutive patients with acute liver failure, admitted over a 41-month period. MEASUREMENTS: Detailed clinical and laboratory data collected during hospitalization, including outcome 3 weeks after study admission. RESULTS: 73% of patients were women; median age was 38 years. Acetaminophen overdose was the most common apparent cause of acute liver failure, accounting for 39% of cases. Idiosyncratic drug reactions were the presumptive cause in 13% of cases, viral hepatitis A and B combined were implicated in 12% of cases, and 17% of cases were of indeterminate cause. Overall patient survival at 3 weeks was 67%. Twenty-nine percent of patients had liver transplantation, and 43% survived without transplantation. Short-term transplant-free survival varied greatly, from 68% for patients with acetaminophen-related liver failure to 25% and 17% for those with other drug reactions and liver failure of indeterminate cause, respectively. Coma grade at admission appeared to be associated with outcome, but age and symptom duration did not. CONCLUSIONS: Acetaminophen overdose and idiosyncratic drug reactions have replaced viral hepatitis as the most frequent apparent causes of acute liver failure. Apparent cause and coma grade at admission were associated with outcome. Although transplantation may improve patient survival, it was unavailable or unnecessary for most patients.
Cited by
- Drug-induced liver injury: Hy’s rule revisited
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period
- Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States
- Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury
- Hypoxic hepatitis – epidemiology, pathophysiology and clinical management
- Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell–Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury
- Investigation of biomarkers for azole antifungal-induced liver injury using primary human hepatocyte spheroids
- Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism
- Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury
- Comparison of Two Artificial Liver Treatments for Acute Liver Failure: A Retrospective Observational Study
- Performance of Relative Exchangeable Copper for the Diagnosis of Wilson Disease in Acute Liver Failure
- Mechanisms of drug-induced liver injury. [europepmc]
- Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. [europepmc]
- Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. [europepmc]
- Acute liver failure: Summary of a workshop. [europepmc]
- Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. [europepmc]
- Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. [europepmc]
- Vascular disorders of the liver. [europepmc]
- Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. [europepmc]
- The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice. [europepmc]
- Mechanisms of acetaminophen-induced liver necrosis. [europepmc]
- Risk factors for idiosyncratic drug-induced liver injury. [europepmc]
- Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. [europepmc]
- Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. [europepmc]
- Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. [europepmc]
- Drug-induced Liver Injury. [europepmc]
- RETRACTED: Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. [europepmc]
- Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. [europepmc]
- Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. [europepmc]
- Drug-induced acute liver failure. [europepmc]
- Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. [europepmc]
- Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. [europepmc]
- Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity. [europepmc]
- Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study. [europepmc]
- Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away? [europepmc]
- Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver. [europepmc]
Related